The Neuropsychiatry of Parkinson Disease: A Perfect Storm

被引:93
作者
Weintraub, Daniel [1 ,2 ]
Mamikonyan, Eugenia [1 ]
机构
[1] Univ Penn, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA USA
基金
美国国家卫生研究院;
关键词
Anxiety; cognition; dementia; depression; impulse control disorder; Parkinson disease; psychosis; IMPULSE CONTROL DISORDERS; DEEP-BRAIN-STIMULATION; MILD COGNITIVE IMPAIRMENT; DRUG-INDUCED PSYCHOSIS; QUALITY-OF-LIFE; SLEEP BEHAVIOR DISORDER; PROVISIONAL DIAGNOSTIC-CRITERIA; EXCESSIVE DAYTIME SLEEPINESS; NURSING-HOME PLACEMENT; TERM-FOLLOW-UP;
D O I
10.1016/j.jagp.2019.03.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Affective disorders, cognitive decline, and psychosis have long been recognized as common in Parkinson disease (PD), and other psychiatric disorders include impulse control disorders, anxiety symptoms, disorders of sleep and wakefulness, and apathy. Psychiatric aspects of PD are associated with numerous adverse outcomes, yet in spite of this and their frequent occurrence, there is incomplete understanding of epidemiology, presentation, risk factors, neural substrate, and management strategies. Psychiatric features are typically multimorbid, and there is great intra- and interindividual variability in presentation. The hallmark neuropathophysiological changes that occur in PD, plus the association between exposure to dopaminergic medications and certain psychiatric disorders, suggest a neurobiological basis for many psychiatric symptoms, although psychological factors are involved as well. There is evidence that psychiatric disorders in PD are still under-recognized and undertreated and although psychotropic medication use is common, controlled studies demonstrating efficacy and tolerability are largely lacking. Future research on neuropsychiatric complications in PD should be oriented toward determining modifiable correlates or risk factors and establishing efficacious and well-tolerated treatment strategies.
引用
收藏
页码:998 / 1018
页数:21
相关论文
共 364 条
  • [41] Cholinergic denervation occurs early in Parkinson disease
    Bohnen, Nicolaas I.
    Albin, Roger L.
    [J]. NEUROLOGY, 2009, 73 (04) : 256 - 257
  • [42] Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire
    Brennan, Laura
    Siderowf, Andrew
    Rubright, Jonathan D.
    Rick, Jacqueline
    Dahodwala, Nabila
    Duda, John E.
    Hurtig, Howard
    Stern, Matthew
    Xie, Sharon X.
    Rennert, Lior
    Karlawish, Jason
    Shea, Judy A.
    Trojanowski, John Q.
    Weintraub, Daniel
    [J]. MOVEMENT DISORDERS, 2016, 31 (01) : 126 - 134
  • [43] Brooks BR, 2004, NEUROLOGY, V63, P1364
  • [44] Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls
    Burton, EJ
    McKeith, IG
    Burn, DJ
    Williams, ED
    O'Brien, JT
    [J]. BRAIN, 2004, 127 : 791 - 800
  • [45] Insomnia and depressive symptoms in patients with Parkinson's disease - Relationship to health-related quality of life. An interview study of patients living at home
    Caap-Ahlgren, M
    Dehlin, O
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2001, 32 (01) : 23 - 33
  • [46] Depression in Parkinson's disease: Convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus
    Cardoso, Ellison Fernando
    Maia, Fernanda Martins
    Fregni, Felipe
    Myczkowski, Martin Luis
    Melo, Luciano M.
    Sato, Joao R.
    Marcolin, Marco Antonio
    Rigonatti, Sergio P.
    Cruz, Antonio Cesario, Jr.
    Barbosa, Egberto Reis
    Amaro, Edson, Jr.
    [J]. NEUROIMAGE, 2009, 47 (02) : 467 - 472
  • [47] Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
    Caspell-Garcia, Chelsea
    Simuni, Tanya
    Tosun-Turgut, Duygu
    Wu, I-Wei
    Zhang, Yu
    Nalls, Mike
    Singleton, Andrew
    Shaw, Leslie A.
    Kang, Ju-Hee
    Trojanowski, John Q.
    Siderowf, Andrew
    Coffey, Christopher
    Lasch, Shirley
    Aarsland, Dag
    Burn, David
    Chahine, Lana M.
    Espay, Alberto J.
    Foster, Eric D.
    Hawkins, Keith A.
    Litvan, Irene
    Richard, Irene
    Weintraub, Daniel
    [J]. PLOS ONE, 2017, 12 (05):
  • [48] Effects of orthostatic hypotension on cognition in Parkinson disease
    Centi, Justin
    Freeman, Roy
    Gibbons, Christopher H.
    Neargarder, Sandy
    Canova, Alexander O.
    Cronin-Golomb, Alice
    [J]. NEUROLOGY, 2017, 88 (01) : 17 - 24
  • [49] Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease
    Chahine, L. M.
    Dos Santos, C.
    Fullard, M.
    Scordia, C.
    Weintraub, D.
    Erus, G.
    Rosenthal, L.
    Davatzikos, C.
    McMillan, C. T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (02) : 246 - +
  • [50] Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder
    Chahine, L. M.
    Xie, S. X.
    Simuni, T.
    Tran, B.
    Postuma, R.
    Amara, A.
    Oertel, W. H.
    Iranzo, A.
    Scordia, C.
    Fullard, M.
    Linder, C.
    Purri, R.
    Darin, A.
    Rennert, L.
    Videnovic, A.
    Del Riva, P.
    Weintraub, D.
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 27 : 102 - 106